Adenosine-induced apoptosis in glomerular mesangial cells  by Zhao, Zhihui et al.
Kidney International, Vol. 61 (2002), pp. 1276–1285
HORMONES – CYTOKINES – SIGNALING
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Adenosine-induced apoptosis in glomerular mesangial cells. lular or extracellular nucleotides by nucleotidases. In glo-
Background. Mesangial cell apoptosis is a mechanism of meruli, nucleotidase (ATPase and ADPase) activity has
resolution of glomerular hypercellularity in inflammatory forms been demonstrated in the glomerular basement mem-of glomerular injury in which adenosine (ADO) was shown to
brane [2] and in mesangial cells [3]. In glomerular inflam-play an anti-inflammatory role. This, and the observation that
mation, adenine nucleotides promote the inflammatorymesangial cell have ADO receptors prompted us to determine
whether ADO induces mesangial cell apoptosis and to explore process by increasing intraglomerular platelet aggrega-
underlying mechanisms. tion and superoxide production by recruited leukocytes
Methods. Cultured mouse mesangial cell were incubated in [4]. Degradation by glomerular nucleotidases would notthe presence or absence of ADO or ADO receptor agonists
only limit their extracellular accumulation but also in-(R-PIA, NECA, IB-MECA, CGS26180) or antagonists (DPCPX,
crease adenosine levels. In a paracrine manner, adeno-DPSPX, MRS1191) for 48 hours. Cell death was assessed by
trypan blue exclusion analysis. Apoptosis was assessed by DNA sine can mediate several responses on glomerular cells
fragmentation, TUNEL staining and flow cytometry. bearing adenosine receptors. Reported responses include
Results. ADO and the A3 ADO receptor agonist IB-MECA
modulation of mesangial cell growth [5], mesangial cellinduced mesangial cell death, which was markedly attenuated
contraction [6], afferent arteriolar constriction [7], inhi-by the A3 receptor antagonist MRS1191. The A1 receptor
agonist R-PIA, A2 receptor agonist NECA or the A2a receptor bition of renin release [8], and modulation of the tubulo-
agonist CGS-12680 had no effect. The IB-MECA–induced glomerular feed back response [9]. The adenosine recep-
mesangial cell death was due to apoptosis. This occurred via tors belong to the G-protein-coupled family and are 320
a cAMP independent mechanism. RT-PCR analysis revealed
to 340 amino acid glycoproteins with seven transmem-presence of A3, A1 and A2b but lack of A2a receptor tran-
brane domains. Four receptor subtypes, termed A1, A2ascripts in MC total RNA. Western blot analysis of mesangial
cell lysates revealed expression the A3 receptor protein only. A2b and A3, have been cloned and identified by pharma-
Conclusion. The observations indicate that ADO induces cological and molecular biological criteria [10–12]. While
mesangial cell apoptosis via stimulation of the A3 receptor. the A2a and A2b receptors interact with Gs to stimulate
adenylyl cyclase activity and elevate intracellular cAMP
levels, the A1 and A3 receptors couple with Gi proteins
Adenosine is an adenine nucleoside that may originate and are associated with two effector signaling systems;
from hydrolysis of adenine nucleotides [adenosine 5-tri- adenylate cyclase and phospholipase C [12]. The avail-
phosphate (ATP), adenosine diphosphate (ADP)] by nu- ability of agonists specific for the four adenosine receptor
cleotidases or from the intracellular enzymatic conversion subtypes has allowed investigators to explore presence
of S-adenosylhomocysteine to adenosine. It is transported and role of these receptors on glomerular cells. Most pub-
in and out of cells by facilitated diffusion through specific lished work involved cultured rodent mesangial cells. It
nucleoside transporter proteins [1]. Adenosine is metab- was shown that stimulation of the A1 or A2 receptor is
olized within seconds by the enzyme adenosine deami- linked to responses such as mesangial cell proliferation,
nase to inosine or is phosphorylated by adenosine kinase modulation of intracellular cAMP levels and stimulation
to form 5-AMP. Adenosine is always present in the extra- of mesangial cell nucleotidase activity [3, 5].
cellular milieu at concentrations in themol/L range, but Mesangial cell hypercellularity is commonly observed
its release is increased following degradation of intracel- in proliferative forms of glomerular injury and its resolu-
tion has been proposed as a mechanism of restoring glo-
merular architecture. For example, in an immune-medi-Key words: mesangial cells, adenosine receptors, cell death, inflamma-
tion, A3 receptor, hypercellularity. ated model of mesangioproliferative glomerulonephritis,
resolution of mesangial hypercellularity can occur via apo-Received for publication May 25, 2001
ptotic cell death [13]. In this model, glomerular nucle-and in revised form September 4, 2001
Accepted for publication November 5, 2001 otidases were shown to play an anti-inflammatory role
[4] attributed to suppressor effects of their product, ade- 2002 by the International Society of Nephrology
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nosine on platelet aggregation, on cytokine release, and ments, cells were incubated in the aforementioned me-
dium in the absence and presence of the adenylyl cyclaseon modulation of leukocyte function [14]. It is unknown
whether the anti-inflammatory role of adenosine in- stimulator forskolin. At completion of incubations with
the above adenosine receptor agonists/antagonists, experi-volves mechanisms other than the aforementioned ef-
fects. One mechanism could involve resolution of glo- ments were terminated and cell number was determined
by trypsinization and counting using a hemacytometer.merular hypercellularity via apoptosis. In this study, we
explored whether adenosine induces mesangial cell apo- Dead cells were identified and counted by the trypan blue
exclusion analysis. Briefly, trypsinized cells were washedptosis and identified the adenosine receptor that medi-
ates apoptotic cell death. with phosphate-buffered saline (PBS) twice, resuspended
in 0.5 mL of PBS at defined dilutions (usually 1:10 vol/
vol) and mixed with an identical volume of trypan blue
METHODS
reagent (available as a 0.4% solution). After thorough
Dulbecco’s modified Eagle’s medium/Ham’s F-12 mixing, aliquots were transferred into the chamber of a
(DMEM/F12), fetal bovine serum (FBS), penicillin/ hemacytometer. Following even distribution of cells into
streptomycin (P/S), and 0.25% trypsin-ethylenediamine- the four quadrants of the hemacytometer, all trypan
tetraacetic acid (EDTA) were purchased from GIBCO blue-positive and -negative cells were counted in each
(Life Technologies, Grand Island, NY, USA). 8-Bromo- quadrant. Results were expressed either as dead (trypan
adenosine 3:5-cyclic monophosphate (8-bromo-cAMP), blue positive) cell counts, or as extent of cell death calcu-
1-Deoxy1-(6-[([3-iodophenyl]methyl)amino]-9H-Purin- lated as percentage of trypan blue-positive cell number/
9-yl)-methyl-b-D-ribofuranuronamide (IB-MECA), trypan blue-positive plus -negative cell number.
3-Ethyl-S-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,
4(/)-dihydropyridine-3,5-dicarboxylate (MRS1191), Identification of apoptosis by the TUNEL assay
2-p-(2-carboxye thy l)phene thylamino-5-N-e thyl- The terminal deoxynucleotidyl transferase-mediated
carboxamino adenosine hydrochloride (CGS21680), nick end-labeling (TUNEL) assay was performed using
5-N-ethyl-carboxamidoadenosine (NECA), N6-(2- the Dead-End Colorimetric Apoptosis Detection System
phenylisopropyl) adenosine (R-PIA), 8-Cyclopentyl-1, (Promega, Madison, WI, USA) according to the manu-
3-dipropylxanthine (DPCPX), 1.3-dipropyl-8-p-sulfophe- facturer’s specifications. Briefly, mesangial cells were
nylxanthine (DPSPX), Adenosine and Forskolin were ob- trypsinized with trypsin-EDTA, washed in PBS, resus-
tained from Sigma Chemical Co. (St. Louis, MO, USA). pended and layered onto poly-l-lysine-coated slides
(Sigma). Cells were then air-dried in a tissue culture hood
Cell cultures for 15 minutes and fixed with 10% buffered formalin for
An SV40 transformed mouse mesangial cell line 25 minutes at room temperature. Cells were subse-
(MES13) obtained from ATCC (Rockville, MD, USA) quently washed three times with PBS and permeabilized
and cultured in DMEM/F12 medium supplemented with by 0.2% triton-X-100 solution in PBS for five minutes
5% heat-inactivated FBS, 14 mmol/L HEPES, 1% P/S at room temperature. After washing twice, cells were
was used in all experiments. Cells were grown at 37C equilibrated for 10 minutes in equilibration buffer [200
under 5% CO2, 95% air. mmol/L potassium cacodylate, pH 6.6, 25 mmol/L Tris-
HCl, pH 6.6, 0.2 mmol/L dithiothreitol (DTT), 0.25
Use of adenosine receptor agonists/antagonists mg/mL BSA, 2.5mmol/L cobalt chloride], and incubated
Mesangial cell were suspended in DMEM/F12 me- in TdT reaction mixture (equilibration buffer 98 L,
dium containing 5% FBS, 14 mmol/L HEPES and 1% Biotinylated Nucleotide mix 1 L, and TdT enzyme 1
P/S, and plated in 24-well culture dishes at a density of L; total volume 100 L) at 37C for 60 minutes in
1  104 cells/well. After incubation for 12 hours, cells humidified chambers. After immersing the slides in 2 
were fed DMEM/F12 containing insulin-transferrin- SSC (NaCl, sodium citrate) for 15 minutes at room tem-
selenium (ITS), 14 mmol/L HEPES and 1% P/S for 48 perature and washing the slides twice in PBS, endoge-
hours to achieve growth arrest. Cells were subsequently nous peroxidases were blocked by immersing the slides
incubated with DMEM/F12 containing ITS, 14 mmol/L in 0.3% hydrogen peroxide for five minutes at room
HEPES and 1% P/S for another 48 hours in the absence temperature. Slides were then incubated with horserad-
and presence of either: adenosine alone, the A3 adeno- ish-peroxidase-labeled streptavidin (HRP) solution for
sine receptor agonist IB-MECA, the A2 adenosine re- 30 minutes and washed twice with PBS. Finally, slides
ceptor agonist NECA, the A2a adenosine receptor ago- were incubated with diaminobenzidine (DAB) compo-
nist CGS21680, the A1 adenosine receptor agonist R-PIA, nents (DAB substrate, DAB chromogen, and hydrogen
the A3 adenosine receptor antagonist MRS1191, the A1 peroxide) for 10 minutes, rinsed three times in deionized
adenosine receptor antagonist DPCPX, or the A2 ade- water, and examined under a light microscope. One hun-
dred cells were examined in each of five random fieldsnosine receptor antagonist DPSPX. In separate experi-
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and those demonstrating apoptotic (dark brown col- 20C overnight and, after centrifugation, DNA pellets
were washed with 75% ethanol and air-dried. DNA elec-ored) nuclei were identified as TUNEL-positive cells
and counted. Results were expressed as percentage of trophoresis was carried out in 1.5% agarose gels contain-
ing 1 mg/mL ethidium bromide. DNA fragments wereTUNEL-positive cell number/TUNEL-positive plus
TUNEL-negative cell number. visualized by exposing the gel to UV light.
Assay of cAMP productionIdentification of apoptosis by flow cytometry
An apoptosis detection method was employed based A commercially available method (kit) was employed
using the manufacturer’s instructions. Briefly, mesan-on use of a monoclonal antibody against the nucleotide
bromodeoxyuridine triphosphate (Br-dUTP). This nu- gial cells were incubated in standard 96-well plates in
DMEM/F12 medium containing ITS, 14 mmol/L HEPES,cleotide becomes incorporated in a template indepen-
dent manner to the 3-hydroxyl ends of double and and 1% P/S at 37C overnight. Cells were subsequently
incubated with or without adenosine or the adenosinesingle stranded DNA strand breaks. Incorporation is
catalyzed by deoxynucleotidyl transferase (TdT). In- receptor agonist IB-MECA for 10 minutes at 37C. Ex-
cess culture media were aspirated and 200 L/well ofcorporated Br-dUTP and, therefore, DNA break sites,
are identified by a FITC-labeled anti-BrdU monoclonal diluted lysis reagent 1B (0.25% solution of dodecyltri-
methylammonium bromide) was added under constantantibody. A commercially available kit (APO-BRDU kit;
PharMingen, San Diego, CA, USA) and the manufac- shaking for 10 minutes. One hundred microliters of lysis
reagent 1B were mixed with 100 L of unknown sampleturer’s instructions were employed. Briefly, mesangial
cells were cultured in six well plates in DMEM/F12 me- (cell lysate) and with 100 L of antiserum (rabbit anti-
cAMP) for two hours at 4C. Fifty microliters of cAMP-dium containing ITS, 14 mmol/L HEPES and 1% P/S
with or without adenosine (ADO) or the ADO A3 recep- peroxidase conjugate were added into all wells except the
blank and incubated at 4C for 60 minutes. Wells weretor agonist (IB-MECA) for 48 hours. After incubation
and trypsinization, cells were fixed with 1% paraformal- washed four times with 400 L wash buffer (0.01 mol/L
phosphate buffer, pH 7.5, 0.05% Tween 20) and 150 Ldehyde in PBS and placed on ice for 15 minutes. Cells
were then washed twice in PBS, exposed to ice-cold 70% enzyme substrate (3,3,5,5-tetramethylbenzidine/hydro-
gen peroxide, 20% dimethylformamide) was immedi-ethanol and placed at 20C overnight. Cells were sub-
sequently washed twice, centrifuged, and resuspended ately dispensed into all wells and incubated for 60 min-
utes at room temperature. Sulfuric acid (0.1 mol/L) wasin 50 L of DNA labeling solution for 60 minutes at 37C
under shaking every 15 minutes to keep them suspended. then added into each well, mixed, and the optical density
was determined in a plate reader at 450 nm within 30Cells were then washed twice with rinse buffer and pel-
lets were resuspended in 100 L of a fluorescein-labeled minutes. Results were expressed as fmol of cAMP/well.
anti-Brdu antibody solution in the dark for 30 minutes
RT-PCR analysis for detection of adenosine receptorat room temperature. Five hundred microliters of a pro-
mRNA transcriptspidium iodine (PI)/RNase A solution was then added
for 30 minutes at room temperature and cells were ana- Total RNA isolated from mesangial cells was reverse
transcribed and the single-stranded cDNA productslyzed by flow cytometry (Becton Dickinson, San Jose,
CA, USA). were denatured and subjected to polymerase chain reac-
tion (PCR) amplification (35 cycles) with each of the
Identification of apoptosis by DNA following primers.
fragmentation analysis
Cells (1107) were lysed in a 0.8 mL cell lysis solution A1 receptor: forward 5-CTCCATCCGAATTCCAC
TCCGGTA-3, reverse 5-ACACTGCCGTTGGCTcontaining 20 mmol/L Tris-HCl, pH 7.4, 0.1 mol/L NaCl,
5 mmol/L EDTA and 0.5% sodium dodecyl sulfate CTC-3.
A2a receptor: forward 5- CCATGCTGGGCTGGA(SDS). Lysates were incubated with 100 g/mL protein-
ase K at 37C overnight. The proteinase K digested ly- ACA-3, reverse 5-GAAGGGGCAGTGACACG
AACG-3.sates were mixed with 0.8 mL phenol/chloroform (1:1),
and the mixture was centrifuged at 14,000  g for 20 A2b receptor: forward 5-TGGCGCTGGAGCTGGT
TA-3, reverse 5-GCAAAGGGGATGGCGAAG-3.minutes. DNA in the aqueous phase was incubated with
5 g/mL DNase-free RNase A at 37C for one hour A3 receptor: forward 5- CCATGTTTGGCTGGAA
TAGA-3, reverse 5-AGAGCCTGCAAGCTCTGand extracted with phenol/chloroform again. DNA was
collected by precipitation performed by mixing the aque- TGG-3).
ous (DNA containing) phase with an identical volume
of isopropanol and addition of 0.1 mL of 5 mol/L NaCl Each PCR cycle consisted of denaturing at 95C for
30 seconds, annealing at 55C for 30 seconds, and exten-to this mixture. Precipitation was allowed to occur at
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Fig. 1. (A) Adenosine dose-dependently decreases mesangial cell number. Cells were incubated with adenosine at concentrations from 1 mol/L
to 1000 mol/L. Cell number was determined following trypsinization and counting in a hemacytometer. *P  0.01 compared to control (absence
of adenosine). **P  0.05 compared to control. (B) Adenosine dose-dependently increases extent of mesangial cell death. Cells were incubated
with adenosine at concentrations from 1 mol/L to 1000 mol/L. Trypan blue-positive (dead) cells were identified and quantified as described in
the Methods section.
sion at 72C for 60 seconds. PCR products were run on 2% jugated anti-goat serum (diluted 1:2500 in TBST with
agarose gel and examined by ethidium bromide staining. 3% nonfat dry milk). Immunoreactivity was detected
using the enhanced chemiluminescence system (ECL;
Preparation of cell lysates, immunoprecipitation and Amersham, Piscataway, NJ, USA).
Western blot analysis
Mesangial cells were collected by centrifugation at Statistical analyses
1500  g for seven minutes. Pellets were washed with Results are presented as mean  SD, and were ana-
PBS and lysed on ice with 0.5 mL immunoprecipitation lyzed using t test statistics for unpaired observations.
buffer (20 mmol/L HEPES, pH 7.9, 1 mmol/L EDTA,
Significance was established when the probability (P)1 mmol/L DTT, 0.1% Tween 20, 10% glycerol) con-
value was less than 0.05.taining 0.4 mol/L NaCl, and protease inhibitors for 30
minutes. Pellets were centrifuged at 14,000 g to remove
cellular debris. Protein concentration of the lysates was
RESULTS
determined using the Bradford method (Bio-Rad, Her-
Adenosine reduces mesangial cell numbercules, CA, USA). Lysates containing equal amounts of
protein were incubated with 2g of either anti-A3 recep- Figure 1A demonstrates the effect of adenosine (ADO)
tor or anti-A1 receptor or anti-A2a receptor or anti-A2b employed at concentration range from 1 mol/L to 1000
receptor antibody (Santa Cruz Technology, Santa Cruz, mol/L on mesangial cell number following a 48 hour
CA, USA) for one hour at 4C. The antigen-antibody incubation. A dose-dependent decrease was observed at
complexes formed were precipitated by mixing with pro- concentrations from 100 mol/L to 1000 mol/L. To ex-
tein G-agarose (Santa Cruz Technology) and agitating plore whether the decrease in cell number was due to
at 4C overnight. Immune complexes were collected by cell death, we performed trypan blue exclusion analy-
centrifugation at 1,500  g for five minutes at 4C, sis. As shown in Figure 1B, ADO dose-dependently in-
washed four times with PBS, run on 4% to 20% gradient creased extent of cell death at concentrations from 100
polyacrylamide gels and electrophoretically transferred
mol/L to 1000 mol/L.to nitrocellulose membranes. Membranes were blocked
overnight at 4C with 5% nonfat dry milk in TBST (10
Adenosine induces mesangial cell death via
mmol/L Tris-HCl, pH 7.5, 140 mmol/L NaCl, 1.5 mmol/L
stimulation of the A3 receptorMgCl2, 0.05% Tween 20) and incubated with the afore-
To explore the type of adenosine receptor via whichmentioned primary antibodies (1:500 dilution in TBST
ADO induces cell death, mesangial cell were incubatedwith 3% nonfat dry milk) for 30 minutes. After washing
in the presence or absence of agonists specific for the A1,in TBST three times (15 min each wash), membranes
were incubated with horseradish peroxidase (HRP)-con- A2a, A2b and A3 adenosine receptors. As shown in Fig-
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Fig. 2. Adenosine induces mesangial cell death via stimulation of the
A3 receptor. Mesangial cell were incubated with or without adenosine Fig. 4. Specificity of A3 receptor-mediated mesangial cell death. Cells
receptor agonists specific for the A1 (R-PIA), A2 (NECA), A2a (CGS- were incubated with the A3 adenosine receptor agonist IB-MECA in
26180), or A3 (IB-MECA) receptors or with adenosine alone. Data the absence and presence of the A3 receptor antagonist MRS1191 or
presented are from of one of three separate experiments. Each bar is in the presence of the A1 receptor antagonist DPCPX or of the A2
the mean  SD of N 	 8 observations. *P  0.01 compared to control. receptor antagonist DPSPX. Data presented are from one of two sepa-
rate experiments. Each bar is the mean  SD of N 	 5 observations.
*P  0.01 compared to IB-MECA.
Fig. 3. The A3 adenosine receptor agonist IB-MECA dose-depen-
dently induces mesangial cell death. Data presented are from one of
three separate experiments. Each bar is the mean  SD of N 	 5
observations; *P  0.01.
ure 2, the A3 receptor agonist IB-MECA induced cell
death the magnitude of which was comparable to that
of ADO alone. The A2a, A2b or A1 receptor agonists
had no effect. The A3 receptor agonist IB-MECA dose-
dependently induced MC death when employed at con-
centrations higher than 10 mol/L (Fig. 3). To explore
specificity of mesangial cell death induced by A3 recep-
tor stimulation, cells were incubated with the A3 recep-
Fig. 5. Agarose gel electrophoresis of DNA extracts from mesangialtor agonist IB-MECA in the presence of the A3 receptor
cells incubated with the A3 adenosine receptor agonist IB-MECA (30antagonist, MRS1191. MRS1191 markedly attenuated
mol/L). Lane 1, DNA markers; lane 2, electrophoretic pattern of DNA
the extent of cell death (Fig. 4). In contrast, incubation extracts from IB-MECA treated mesangial cells; lane 3, electrophoretic
pattern of DNA extracts from control (untreated) cells.with the A3 receptor agonist IB-MECA in the presence
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Fig. 6. Apoptotic cells identified by light mi-
croscopy as cells having dark brown nuclei
(Methods section). (A) preparation of control
cells. (B) Preparation of mesangial cells ex-
posed to the A3 receptor agonist IB-MECA.
of either the A1 receptor antagonist DPCPX or the A2 ence of A3, A1 and A2b receptor mRNA transcripts but
lack of A2a transcripts (Fig. 9). Immunoprecipitationreceptor antagonist DPSPX had no effect (Fig. 4).
of A3 receptor protein from mesangial protein lysates
A3 receptor-mediated mesangial cell followed by Western blot analysis revealed a single 70 kD
death is apoptotic band (Fig. 10, lane 2) that co-migrated with A3 receptor
To explore whether mesangial cell death induced by protein present in mouse heart protein lysates (used as
stimulation of the A3 adenosine receptor was due to a positive control standard) that were electrophoresed
apoptosis, we assessed and quantified presence of apo- in parallel. Immunoprecipitation of A1, or A2a or A2b
ptotic cells by demonstrating DNA fragmentation in aga- receptor protein from mesangial cell lysates followed by
rose gels, by performing the TUNEL assay and by per- Western blot analysis revealed no detectable bands in
forming flow cytometry using an anti-BrdU monoclonal Western blots (data not shown).
antibody as described in the Methods section. As shown
in Figure 5, lane 2, incubation of mesangial cell with the
DISCUSSIONA3 receptor agonist IB-MECA (30 mol/L) induced a
Our observations demonstrate that murine mesangialDNA ladder pattern characteristic of DNA fragmenta-
cells undergo cell death when exposed to adenosine. Celltion. Figure 6B demonstrates presence of cells with apo-
death was identified by the well-established trypan blueptotic (dark brown colored) nuclei (TUNEL positive
exclusion analysis method. Trypan blue positivity cannotcells) in a preparation of MC incubated with the A3
distinguish apoptotic from necrotic cell death, as cellsreceptor agonist IB-MECA (30 mol/L). Figure 7 dem-
that are in late stages of apoptosis (also referred to asonstrates extent of apoptosis assessed by flow cytometry
secondary necrosis) can also be trypan blue-positive. Tousing the anti-BrdU monoclonal antibody. Both ADO
confirm that adenosine-induced mesangial cell death was(300 mol/L) and the A3 receptor agonist IB-MECA
apoptotic, we employed three established methods that(30 mol/L) increased apoptotic cell number (Fig. 7 C
detect apoptosis: DNA fragmentation, TUNEL assay,and E compared to A). The specificity of A3 receptor-
and flow cytometry using a monoclonal antibody againstmediated apoptotic cell death is shown in Figure 8. Ade-
BrdU. These methods confirmed apoptosis following ex-nosine dose-dependently increased percentage of TU-
posure of mesangial cells to adenosine (Figs. 7C andNEL positive cells (identified and quantified by
Fig. 8). Using a specific agonist for the A3 adenosinemicroscopy as shown in Fig. 6). The A3 receptor agonist
receptor, we demonstrated that the adenosine-inducedIB-MECA (60mol/L) increased percentage of TUNEL
apoptotic cell death was mediated via stimulation of thepositive cells to 58.6%. Coincubation of MC with IB-
A3 receptor (Figs. 5, 6 and 7). Thus, the extent of apopto-MECA and the A3 receptor antagonist MRS1191 sig-
sis in response to adenosine was comparable to that innificantly reduced percentage of TUNEL positive cells
response to the adenosine A3 receptor agonist IB–to 15%.
MECA (Fig. 7 C, E), and the A3 receptor antagonist
Adenosine receptor expression in mesangial cells MRS1191 attenuated apoptotic death induced both by
adenosine and by the A3 adenosine receptor agonistReverse transcription-polymerase chain reaction (RT-
PCR) analysis of total mesangial cell RNA revealed pres- IB–MECA (Fig. 7 D, F). The specificity of A3 receptor-
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Fig. 9. Expression of adenosine receptor sequences identified by RT-
PCR. Total mesangial cell RNA was analyzed by RT-PCR using primersFig. 8. Specificity of mesangial cell apoptosis induced by stimulation
designed for A1, A2a, A2b and A3 receptor published sequences. Laneof the adenosine A3 receptor. Mesangial cells were incubated with
1, DNA markers; lane 2, A3 receptor; lane 3, A1 receptor; lane 4, A2aadenosine or with the adenosine A3 receptor agonist IB-MECA in the
receptor; lane 5, A2b receptor.presence or absence of the A3 receptor antagonist MRS1191. Apoptotic
cells were identified as TUNEL positive cells and quantified as described
in the Methods section. Data presented are from one of two separate
experiments. Each bar is the mean  SD of N 	 5 observations. *P 
0.01 compared to control; **P  0.01 compared to IB-MECA. proliferation [5]. None of these studies identified or char-
acterized adenosine receptors at the molecular (RNA
or protein) level. Using RT-PCR, we demonstrate that
murine mesangial cells express A1, A2b and A3 receptor,mediated apoptotic cell death was further demonstrated
but not A2a receptor transcripts (Fig. 9). Using immuno-in the experiment shown in Figure 4; cell death following
precipitation followed by Western blot analysis we couldA3 receptor stimulation by the A3 receptor agonist IB–
only identify A3 receptor protein (Fig. 10). The inabilityMECA was attenuated by the A3 receptor antagonist
to detect A1 or A2 receptor protein indicates eitherMRS1191, but not by the A1 receptor antagonist DPCPX
that there is no translation of mRNA to protein or thator by the A2 receptor antagonist DPSPX.
abundance of these receptor proteins in cell lysates wasAlthough the presence of mesangial cell adenosine
not of sufficient amounts to be immunoprecipitated or toreceptors was previously described, those observations
be detected by the antibodies employed. These findings,were based solely on use of agonists for the A1 receptor
taken together with the observation that cell death (the(compound R-PIA) or for the A2 receptor (compound
outcome of main interest in the present studies) wasNECA). Thus, Olivera and Lopez-Novoa described that
induced only via stimulation of the A3 adenosine recep-the A1 receptor agonist R-PIA decreases while the A2
tor (Fig. 2), indicate that only the A3 receptor is linkedreceptor agonist NECA increases intracellular cAMP
to mesangial cell apoptotic death.levels in rat mesangial cells [15]. Using labeled NECA,
As mentioned earlier, adenosine receptor stimulationStefanovic et al demonstrated that mesangial cells bear
was shown to modulate cAMP levels in mesangial cells.the A2 receptor and confirmed that stimulation of this
To explore the functional significance of the adenosinereceptor increases rat mesangial cells cAMP levels [3].
receptor types identified by RT-PCR or Western blotMacLaughlin et al used the A1 receptor agonist R-PIA
analysis (Figs. 9 and 10), we measured cAMP levels fol-and the A2 receptor agonist NECA to demonstrate that
stimulation of either receptor induced rat mesangial cell lowing incubation of mesangial cells with the various

Fig. 7. Detection of mesangial cell apoptosis by flow cytometry performed as described in the Methods section. (A) Control (untreated mesangial
cells). (B) Mesangial cells incubated with the A3 receptor antagonist MRS1911. (C ) Mesangial cells incubated with adenosine (300 mol/L). (D)
Mesangial cells incubated with adenosine in the presences of the adenosine A3 receptor antagonist MRS1911. (E ) Mesangial cells incubated with
the adenosine A3 receptor agonist IB–MECA (30 m). (F ) Mesangial cells incubated with the A3 receptor agonist IB–MECA (30 m) in the
presence of the A3 receptor antagonist MRS1191. Cells that stain positive with the fluorescein-BrdU mAb cluster in the upper box (above the
horizontal line). Negative cells cluster in the lower box.
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Fig. 10. A3 receptor protein expression. Mes-
angial cell protein lysates were immunopre-
cipitated with an anti-A3 receptor polyclonal
antibody. Immune complexes were electropho-
resed on 4-20% SDS-PAGE gels and trans-
ferred to a nitrocellulose membrane. A3 re-
ceptor protein was identified as a 70 kD band
(lane 2) comigrating with a similar kD band
originating from mouse heart protein extracts
that are rich in the A3 receptor protein and
used as a positive control (lane 1).
Table 1. Concentration of cAMP in mesangial cells ulation. This is further strengthened by the observation
that the adenosine A3 receptor agonist IB-MECA, theAgonist cAMP fmol/well
only agonist that induced apoptotic cell death (Fig. 2),Control 43.294.48
Adenosine 300 lmol/L 53.853.92a did not increase cAMP levels (Table 1). Rather, it at-
R-PIA 100 nmol/L 43.065.84 tenuated the increase in cAMP levels induced by for-
NECA 100 mol/L 59.609.25a
skolin (Table 1). Taken together, these observations in-CGS 12680 50 nmol/L 65.0018.22
IB-MECA 30 nmol/L 49.2917.82 dicate that mesangial cell apoptosis following adenosine
IB-MECA 100 nmol/L 54.697.3 receptor stimulation occurs independently of changes in
Forskolin 10 mmol/L 9090.5195a
cAMP levels.IB-MECA 100 nmol/L
 forskolin 10 mmol/L 6335.599.5b Studies on mechanisms underlying apoptosis induced
by A3 receptor stimulation in other cell types have im-a P  0.05 compared to control
b P  0.005 compared to forskolin alone plicated phospholipase C activation [16, 17], enhanced ex-
pression of the pro-apoptotic gene bak [18], decreased
expression of the anti-apoptotic gene bcl-2, and increased
levels of caspase-3, a cytosolic protease believed to playreceptor agonists employed. As shown in Table 1, adeno-
a central role in cleavage of intracellular proteins andsine and the adenosine A2 receptor agonist NECA sig-
in the development of apoptotic morphology [19].nificantly increased cAMP levels, while the A1 receptor
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significant effects. The observation that A2 receptor
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ceptor using the NECA agonist significantly increased ever, in non-proliferative forms of glomerular injury ex-
cAMP levels (Table 1) but did not induce apoptotic cell emplified by glomerulosclerosis developing in the rat
death (Fig. 2) indicates that cAMP (known to be a potent remnant kidney model, apoptosis may be involved in the
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